Utama › Kanser Paru-paru Bukan Sel Kecil › Illinois › Evanston
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Evanston, IL
22 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Evanston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi jauh
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
- dan 1 lagi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Mengambil pesertaFasa 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Mengambil pesertaFasa 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Illinois Cancer Specialists, Niles · 6 mi jauh
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Mengambil pesertaFasa 3
- Illinois Cancer Specialists, Niles · 6 mi jauh
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Mengambil pesertaFasa 3
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 2
- Illinois Cancer Specialists /ID# 274678, Niles · 6 mi jauh
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Mengambil pesertaFasa 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Mengambil pesertaFasa 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · 6 mi jauh
- Advocate Medical Group Oncology, Park Ridge · 8 mi jauh
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Mengambil pesertaKajian pemerhatian
- Orchard Healthcare Research Inc., Skokie · 2 mi jauh
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Mengambil pesertaFasa 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · 2 mi jauh
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Mengambil pesertaFasa 3
- Research Site, Niles · 6 mi jauh
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Mengambil pesertaFasa 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Mengambil pesertaFasa 2
- Advocate Aurora Health, Park Ridge · 8 mi jauh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauh
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauh
GEMINI-NSCLC: NSCLC Biomarker Study
Mengambil pesertaKajian pemerhatian
- Northwestern University, Evanston
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY120 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH56 kajian
- Washington, DC55 kajian
Kajian lain di Evanston
- Kanser Paru-paru19 kajian
- Kanser Payudara13 kajian
- Leukemia Mieloid Akut11 kajian
- Obesiti11 kajian
- Kanser Kolorektal10 kajian
- Kanser (semua jenis)9 kajian
- Berat Badan Berlebihan9 kajian
- Kolitis Ulseratif9 kajian
- Kanser Prostat9 kajian
- Penyakit Crohn9 kajian
- Kegagalan Jantung8 kajian
- Fibrilasi Atrium8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.